Ting Wen

Ting Wen

Auto-generated profile, based on publicly available information

Ting Wen

Department of Orthopedics, Xiangya Hospital, Central South University, Hunan, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PTPeiyuan Tang
Peiyuan Tang
YCYangbin Cao
Yangbin Cao
Djandan Tadum Arthur VithranDjandan Tadum Arthur Vithran
Djandan Tadum Arthur Vithran
WXWenfeng Xiao
Wenfeng Xiao
TWTing Wen
Ting Wen
Yusheng LiYusheng Li
Yusheng Li
Background: Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. Objective: To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. Methods: The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. Results: This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). Conclusions: VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. Trial Registration: PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469

4 August 2025 in Journal of Global Health
Verified
Journal Article
Open access
HTHan Tan
Han Tan
PTPeiyuan Tang
Peiyuan Tang
HCHua Chai
Hua Chai
WMWenbo Ma
Wenbo Ma
YCYangbin Cao
Yangbin Cao
Yusheng LiYusheng Li
Yusheng Li
Bone and joint disorders significantly contribute to disability worldwide. While meta-analyses have explored the relationship of these diseases and beverage consumption, the results remain inconsistent. In this umbrella review, we synthesised existing evidence to clarify these associations. We conducted a systematic search in PubMed, Embase, Cochrane, and Web of Science up to January 2025. Two independent reviewers screened studies and extracted data based on predefined criteria. We included meta-analyses and systematic review studies. We used the Graphical Representation of Overlap for Overviews tool to manage overlapping studies and assessed methodological quality and evidence levels using AMSTAR 2 tool and the GRADE system. We narratively synthesised the findings and summarised them in tables. We included 20 meta-analyses. Tea consumption was associated with a reduced risk of osteoporosis (odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.60, 0.83; P < 0.0001; I2 = 13%), while coffee showed mixed results. Alcohol intake increased osteoporosis risk (OR = 2.95; 95% CI = 1.78, 4.9; P < 0.0001; I2 = 0%). Sugar-sweetened beverages raised gout risk (relative risk (RR) = 1.35; 95% CI = 1.18, 1.55, P < 0.05; I2 = 40.1%) and serum uric acid levels, while coffee lowered gout risk (RR = 0.43; 95% CI = 0.31, 0.59; P < 0.001; I2 = 0%). Coffee was associated with a higher risk of rheumatoid arthritis (RR = 1.3; 95% CI = 1.04, 1.62; P < 0.05; I2 = 0%), while tea showed no significant effect. Tea may benefit bone and joint health, while alcohol and sugar-sweetened beverages are associated with a higher incidence of bone and joint conditions, such as osteoporosis, rheumatoid arthritis, and gout. These findings emphasise the importance of dietary choices in preventing bone and joint disorders. PROSPERO (CRD42024551504).

21 July 2024 in JMIR Preprints
Verified
Preprint
Open access
PTPeiyuan Tang
Peiyuan Tang
YCYangbin Cao
Yangbin Cao
Djandan Tadum Arthur VithranDjandan Tadum Arthur Vithran
Djandan Tadum Arthur Vithran
WXWenfeng Xiao
Wenfeng Xiao
TWTing Wen
Ting Wen
Yusheng LiYusheng Li
Yusheng Li
BACKGROUND Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. OBJECTIVE To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. METHODS The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. RESULTS This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). CONCLUSIONS VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. CLINICALTRIAL PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469